1.
Kim S-H, Menon H, Jootar S, Saikia T, Kwak J-Y, Sohn S-K, Park JS, Jeong SH, Kim HJ, Kim Y-K, Oh SJ, Kim H, Zang DY, Chung JS, Shin HJ, Do YR, Kim J-A, Kim D-Y, Choi CW, Park S, Park HL, Lee GY, Cho DJ, Shin JS, Kim D-W. Efficacy and safety of radotinib in chronic phase chronic myeloid leukemia patients with resistance or intolerance to BCR-ABL1 tyrosine kinase inhibitors. Haematologica [Internet]. 2014Jul.1 [cited 2026Nov.16];99(7):1191-6. Available from: https://haematologica.org/article/view/7083